Chen Bihua Insider Trades

Insider Trading History

Track insider trading activity for Chen Bihua. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
MoonLake Immunotherapeutics
MoonLake Immunotherapeutics MLTX
other, Former 10% Owner
Holding Value $36.4M 1,994,173 shares
Last Trade
Sep 30, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$40.6k 5,827 shares
$6.96
$18.27
MoonLake Immunotherapeutics
MoonLake Immunotherapeutics MLTX
other, Former 10% Owner
Holding Value $154M 8,423,403 shares
Last Trade
Sep 29, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$40.6M 6,494,151 shares
$6.24
$18.27
Helix Acquisition II
Helix Acquisition II HLXB
10% owner
Holding Value $0 0 shares
Last Trade
Aug 11, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$41.3M 4,172,126 shares
$9.90
$9.90
Helix Acquisition II
Helix Acquisition II HLXB
10% owner
Holding Value $58.9M 5,952,356 shares
Last Trade
Aug 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$75M 6,998,031 shares
$10.72
$9.90
Helix Acquisition II
Helix Acquisition II HLXB
10% owner
Holding Value $46.3M 4,681,126 shares
Last Trade
Aug 11, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$41.3M 4,172,126 shares
$9.90
$9.90
Biomea Fusion
Biomea Fusion BMEA
10% owner
Holding Value $120k 91,970 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$230k 91,970 shares
$2.50
$1.30
Helix Acquisition II
Helix Acquisition II HLXB
10% owner, CEO And Chairperson
Holding Value $44.4M 4,480,000 shares
Last Trade
Feb 08, 2025 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$324k 30,000 shares
$10.80
$9.90
Helix Acquisition
Helix Acquisition HLXA
10% owner, CEO And Chairperson
Holding Value $59.4M 4,480,000 shares
Last Trade
Feb 08, 2025 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$398k 30,000 shares
$13.25
$13.25
Biomea Fusion
Biomea Fusion BMEA
10% owner
Holding Value $66.3 51 shares
Last Trade
Jun 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$236k 51,025 shares
$4.63
$1.30
MoonLake Immunotherapeutics
MoonLake Immunotherapeutics MLTX
10% owner
Holding Value $155M 8,494,151 shares
Last Trade
Oct 05, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.52M 58,839 shares
$59.90
$18.27
MoonLake Immunotherapeutics
MoonLake Immunotherapeutics MLTX
10% owner
Holding Value $154M 8,435,312 shares
Last Trade
Oct 04, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.89M 67,814 shares
$57.32
$18.27
MoonLake Immunotherapeutics
MoonLake Immunotherapeutics MLTX
10% owner
Holding Value $153M 8,367,498 shares
Last Trade
Oct 03, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$8.62M 150,487 shares
$57.25
$18.27
MoonLake Immunotherapeutics
MoonLake Immunotherapeutics MLTX
10% owner
Holding Value $150M 8,217,011 shares
Last Trade
Oct 02, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.3M 74,911 shares
$57.37
$18.27
MoonLake Immunotherapeutics
MoonLake Immunotherapeutics MLTX
10% owner
Holding Value $90M 4,927,100 shares
Last Trade
Jun 30, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$40M 800,000 shares
$50.00
$18.27
MoonLake Immunotherapeutics
MoonLake Immunotherapeutics MLTX
10% owner
Holding Value $75.4M 4,127,100 shares
Last Trade
Jun 26, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$20.5M 450,000 shares
$45.63
$18.27
Erasca
Erasca ERAS
Director
Holding Value $791k 60,000 shares
Last Trade
Jun 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$160k 60,000 shares
$2.66
$13.18
Biomea Fusion
Biomea Fusion BMEA
10% owner
Holding Value $9.09k 6,989 shares
Last Trade
Jun 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$272k 6,989 shares
$38.90
$1.30
Biomea Fusion
Biomea Fusion BMEA
10% owner
Holding Value $4.64M 3,570,872 shares
Last Trade
Mar 30, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$12M 400,000 shares
$30.00
$1.30
Erasca
Erasca ERAS
Director
Holding Value $143M 10,813,246 shares
Last Trade
Dec 13, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.52M 307,692 shares
$4.93
$13.18
Erasca
Erasca ERAS
Director
Holding Value $143M 10,813,246 shares
Last Trade
Dec 13, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.52M 307,692 shares
$4.93
$13.18

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up